Moreover, the STZ capability to develop insulin-dependent diabetes mellitus (type 1) by thorough elimination or devastation of pancreatic cells, the STZ is moreover having the capability of producing peripheral insulin resistance (type 2 diabetes), impairing the glucose oxidation or impairing insulin secretion, decreasing the insulin synthesis and secretion from β-cells. The gene discussed is INS; the disease is type 1 diabetes mellitus.